Sanders Morris Harris LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Sanders Morris Harris LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$4.99 - $8.96 $68,862 - $123,648	-13,800 Closed	0 $0
Q1 2022 Apr 11, 2022	BUY	$3.84 - $9.74 $52,992 - $134,412	13,800 New	13,800 $115,000
Q1 2020 Apr 09, 2020	SELL	$4.91 - $14.7 $233,225 - $698,250	-47,500 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$9.77 - $15.66 $156,320 - $250,560	16,000 Added 50.79%	47,500 $691,000
Q2 2019 Jul 10, 2019	BUY	$9.54 - $14.96 $300,510 - $471,240	31,500 New	31,500 $344,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.